Belgium
Trade With South Africa
| 2021 | |
|---|---|
| Imports from South Africa | $2.4b |
| Exports to South Africa | $1.4b |
Imports from South Africa
Exports to South Africa
Source: United Nations
Top Imports from South Africa
| Description | Trade Value | Trade Quantity1 | Measurement |
|---|---|---|---|
| Natural, cultured pearls; precious, semi-precious stones; precious metals, metals clad with precious metal, and articles thereof; imitation jewellery; coin | $1.60b | ||
| Waste and scrap of precious metal or of metal clad with precious metal; other waste and scrap containing precious metal compounds, of a kind uses principally for the recovery of precious metal | $814.06m | 11.4m | Weight in kilograms |
| Waste and scrap of precious metals; of platinum, including metal clad with platinum but excluding sweepings containing other precious metals | $746.31m | 10.3m | Weight in kilograms |
| Diamonds, whether or not worked, but not mounted or set | $724.85m | 3.7m | Weight in carats |
| Vehicles; other than railway or tramway rolling stock, and parts and accessories thereof | $592.36m | ||
| Vehicles; compression-ignition internal combustion piston engine (diesel or semi-diesel), for transport of goods, (of a gvw not exceeding 5 tonnes), n.e.c. in item no 8704.1 | $581.81m | 19.87k | Number of items |
| Vehicles; for the transport of goods | $581.81m | 19.87k | Number of items |
| Diamonds; non-industrial, unworked or simply sawn, cleaved or bruted, but not mounted or set | $462.82m | 2.3m | Weight in carats |
| Pharmaceutical products | $215.75m | ||
| Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc | $213.71m | 261.35k | Weight in kilograms |
Top Exports to South Africa
| Description | Trade Value | Trade Quantity1 | Measurement |
|---|---|---|---|
| Pharmaceutical products | $300.83m | ||
| Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc | $238.96m | 102.34k | Weight in kilograms |
| Vaccines; for human medicine | $233.87m | 89.45k | Weight in kilograms |
| Mineral fuels, mineral oils and products of their distillation; bituminous substances; mineral waxes | $183.53m | ||
| Petroleum oils and oils from bituminous minerals, not crude; preparations n.e.c, containing by weight 70% or more of petroleum oils or oils from bituminous minerals; these being the basic constituents of the preparations; waste oils | $168.15m | 331.3m | Weight in kilograms |
| Petroleum oils and oils from bituminous minerals, not containing biodiesel, not crude, not waste oils; preparations n.e.c, containing by weight 70% or more of petroleum oils or oils from bituminous minerals; light oils and preparations | $157.65m | 326.4m | Weight in kilograms |
| Plastics and articles thereof | $129.36m | ||
| Commodities not specified according to kind | $106.14m | ||
| Commodities not specified according to kind | $106.14m | ||
| Commodities not specified according to kind | $106.14m |
1 Not all goods in this category have a common measurement and therefore no measurement is reported.
